✦ LIBER ✦

1208 EVALUATION OF NS3 AMINO ACID VARIANTS IN A PHASE 1B STUDY OF GENOTYPE 1 (GT1) AND GT3 INFECTED PATIENTS WITH THE HCV PROTEASE INHIBITOR, MK-5172

✍ Scribed by Strizki, J.M.; Barnard, R.J.O.; Cheney, C.; McHale, C.; Graham, D.; Himmelberger, A.; Petry, A.; Fraser, I.; Nachbar, R.; Hazuda, D.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potency, safety, and pharmacokinetics of

✍ Michael P. Manns; Marc Bourlière; Yves Benhamou; Stanislas Pol; Maurizio Bonacin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 767 KB

1186 SAFETY AND ANTIVIRAL ACTIVITY OF AB

✍ Lawitz, E.; Marbury, T.; Campbell, A.; Dumas, E.; Kapoor, M.; Pilot-Matias, T.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Prevalence of hepatitis C virus variants

✍ Fumitaka Suzuki; Hitomi Sezaki; Norio Akuta; Yoshiyuki Suzuki; Yuya Seko; Yusuke 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Characterization of vaniprevir, a hepati

✍ Lawitz, Eric; Sulkowski, Mark; Jacobson, Ira; Kraft, Walter K.; Maliakkal, Bened 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 367 KB

1422 POTENT VIRAL SUPPRESSION WITH ALL-O

✍ Sulkowski, M.; Gardiner, D.; Lawitz, E.; Hinestrosa, F.; Nelson, D.; Thuluvath, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 110 KB

13 COMBINATION OF THE NS5A INHIBITOR, GS

✍ Everson, G.T.; Di Bisceglie, A.M.; Vierling, J.M.; Hsieh, F.; Trenkle, J.D.; Kan 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 64 KB